Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.18K Sell
116
-40
-26% -$1.61K ﹤0.01% 2030
2024
Q4
$6.53K Hold
156
﹤0.01% 1862
2024
Q3
$5.04K Buy
156
+60
+63% +$2.37K ﹤0.01% 2013
2024
Q2
$3.73K Buy
96
+13
+16% +$519 ﹤0.01% 2130
2024
Q1
$3.68K Sell
83
-12
-13% -$648 ﹤0.01% 2033
2023
Q4
$5.05K Buy
95
+69
+265% +$3.41K ﹤0.01% 1882
2023
Q3
$1.22K Buy
26
+5
+24% +$220 ﹤0.01% 2299
2023
Q2
$920 Hold
21
﹤0.01% 2382
2023
Q1
$726 Hold
21
﹤0.01% 2518
2022
Q4
$573 Buy
+21
New +$586 ﹤0.01% 2568

Other funds holding BRZE

Lindbrook Capital's BRZE Position: Q1 2025 in Review

Lindbrook Capital reduced its Braze (BRZE) stake by 26% in Q1 2025, selling an estimated $1.61K and leaving 116 shares worth $4.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Lindbrook Capital first reported a position in BRZE in Q4 2022 and has held it in 10 quarters since. The position peaked at $6.53K in Q4 2024. 241 funds tracked by Wall St. Rank hold BRZE as of Q1 2025.

  • Lindbrook Capital held 116 shares of Braze worth $4.18K as of Q1 2025.
  • Lindbrook Capital sold 40 Braze shares in Q1 2025, an estimated $1.61K.
  • Braze made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2030 holding.
  • Lindbrook Capital first reported a position in Braze in Q4 2022 and has held it in 10 quarters since.
  • Lindbrook Capital's Braze position peaked at $6.53K in Q4 2024.
  • 241 funds tracked by Wall St. Rank held Braze as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.